|
End-of-day quote
Buenos Aires S.E.
2026-08-19
|
5-day change | 1st Jan Change | ||
| 155.00 ARS | -1.90% |
|
-1.59% | -35.55% |
| Market Cap | 6.6B 4.41M 3.78M 3.53M 3.24M 6.09M 421M 6.19M 41.66M 16.31M 211M 16.55M 16.19M 699M | P/E 2024 |
-3.67x | P/E 2025 | -2.23x |
|---|---|---|---|---|---|
| Enterprise Value | 7.34B 4.9M 4.2M 3.93M 3.6M 6.77M 468M 6.88M 46.31M 18.14M 235M 18.4M 18M 777M | EV / Sales 2024 |
0.73x | EV / Sales 2025 | 1.71x |
| Free-Float |
19.84% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.90% | ||
| 1 week | -1.59% | ||
| Current month | -2.82% | ||
| 1 month | -2.21% | ||
| 3 months | -7.46% | ||
| 6 months | -27.57% | ||
| Current year | -35.55% |
| 1 week | 153.5 |  | 162.5 |
| 1 month | 150 | | 165 |
| Current year | 128.5 | | 260 |
| 1 year | 116 | | 357 |
| 3 years | 23 | | 450 |
| 5 years | 9.1 | | 450 |
| 10 years | 4.2 | | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Oscar Echeverria
DFI | Director of Finance/CFO | - | 2010-07-29 |
Federico Hoffman
CTO | Chief Tech/Sci/R&D Officer | - | - |
Eduardo Busto
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 2010-07-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.90% | -1.59% | -22.50% | +520.00% | 4.51M | |
| +3.68% | +4.27% | -50.74% | -57.77% | 30.56B | |
| +3.64% | +10.71% | +39.84% | +110.84% | 11.81B | |
| -2.19% | 0.00% | -17.85% | +5.74% | 3.95B | |
| +0.15% | -0.90% | -1.93% | +21.28% | 3.2B | |
| -2.52% | -4.09% | +47.53% | +37.20% | 2.18B | |
| +0.86% | +0.43% | +12.26% | +11.90% | 1.94B | |
| +2.28% | +4.85% | +11.27% | +133.93% | 1.41B | |
| -2.28% | -7.21% | -20.99% | +4.19% | 1.27B | |
| -1.91% | +1.06% | -11.76% | -42.95% | 1.03B | |
| Average | -0.02% | +0.88% | -1.49% | +74.44% | 5.74B | |
| Weighted average by Cap. | +2.47% | +4.38% | -18.35% | -1.91% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 8.27B 5.53M 4.74M 4.43M 4.06M 7.64M 528M 7.76M 52.22M 20.45M 265M 20.75M 20.29M 876M | 6.4B 4.28M 3.67M 3.42M 3.14M 5.91M 409M 6.01M 40.41M 15.82M 205M 16.05M 15.7M 678M |
| Net income | -1.42B -946K -812K -758K -695K -1.31M -90.45M -1.33M -8.94M -3.5M -45.36M -3.55M -3.48M -150M | -4.6B -3.07M -2.63M -2.46M -2.26M -4.24M -293M -4.31M -29.01M -11.36M -147M -11.53M -11.28M -487M |
| Net Debt | 863M 576K 494K 462K 424K 796K 55.09M 810K 5.45M 2.13M 27.63M 2.16M 2.12M 91.35M | 738M 493K 423K 395K 362K 681K 47.08M 692K 4.66M 1.82M 23.61M 1.85M 1.81M 78.07M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-19 | ARS 155.00 | -1.90% | 6,369 |
| 26-08-18 | ARS 158.00 | +1.28% | 15,265 |
| 26-08-14 | ARS 156.00 | -2.50% | 2,457 |
| 26-08-13 | ARS 160.00 | +1.59% | 5,690 |
| 26-08-12 | ARS 157.50 | -2.78% | 2,404 |
- Stock Market
- Stocks
- ROSE Stock
Select your edition
All financial news and data tailored to specific country editions
